- Home
- / GABY
GABY
Stock Price
$0
2024-08-19
Market Capitalization
$2.7 M
2024-08-19
Revenue
$21.8 M
FY, 2022
GABY Summary
Company Summary
- Overview
- GABY is a company that provides pharmaceutical products. It offers cannabis products, including flowers, concentrates, pre-rolls, edibles, topicals, tinctures, and other products.
- Type
- Public
- Status
- Active
- Founded
- 2003
- Website
- https://www.gabyinc.com
- Cybersecurity rating
- Sectors
Table of Contents
GABY Financials
Summary Financials
- Revenue (Q1, 2023)
- $4.7M
- Gross profit (Q1, 2023)
- $2.5M
- Net income (Q1, 2023)
- ($1.6M)
- Cash (Q1, 2023)
- $1.8M
- EBIT (Q1, 2023)
- ($102.0K)
- Enterprise value
- $27.2M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026